NasdaqGS:ALKSBiotechs
Is Alkermes (ALKS) Offering Value After Recent Biotech Sector Reaction To Its Portfolio
If you are wondering whether Alkermes is offering fair value at its current price, this article walks through what the numbers are really saying about the stock.
With the share price at US$30.62, Alkermes has logged returns of 4.3% over the last week, 8.7% over the last month, 8.4% year to date and 5.4% over the past year, with 3 year and 5 year returns of 12.5% and 39.6% respectively. These figures may influence how you think about its risk and return trade off.
Recent news around Alkermes...